<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35777657</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Pathogenic analysis of coxsackievirus A10 in rhesus macaques.</ArticleTitle><Pagination><StartPage>610</StartPage><EndPage>618</EndPage><MedlinePgn>610-618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2022.06.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(22)00113-4</ELocationID><Abstract><AbstractText>Coxsackievirus A10 (CV-A10) is one of the etiological agents associated with hand, foot and mouth disease (HFMD) and also causes a variety of illnesses in humans, including pneumonia, and myocarditis. Different people, particularly young children, may have different immunological responses to infection. Current CV-A10 infection animal models provide only a rudimentary understanding of the pathogenesis and effects of this virus. The characteristics of CV-A10 infection, replication, and shedding in humans remain unknown. In this study, rhesus macaques were infected by CV-A10 via respiratory or digestive route to mimic the HFMD in humans. The clinical symptoms, viral shedding, inflammatory response and pathologic changes were investigated in acute infection (1-11 day post infection) and recovery period (12-180 day post infection). All infected rhesus macaques during acute infection showed obvious viremia and clinical symptoms which were comparable to those observed in humans. Substantial inflammatory pathological damages were observed in multi-organs, including the lung, heart, liver, and kidney. During the acute period, all rhesus macaques displayed clinical signs, viral shedding, normalization of serum cytokines, and increased serum neutralizing antibodies, whereas inflammatory factors caused some animals to develop severe hyperglycemia during the recovery period. In addition, there were no significant differences between respiratory and digestive tract infected animals. Overall, all data presented suggest that the rhesus macaques provide the first non-human primate animal model for investigating CV-A10 pathophysiology and assessing the development of potential human therapies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Suqin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fengmei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beijing Advanced Innovation Center for Soft Matter Science and Engineering College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Weihua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junbin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lixiong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Shaohui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China. Electronic address: shaohuima@imbcams.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhanlong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China. Electronic address: hzl@imbcams.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qihan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China. Electronic address: liqihan@imbcams.com.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044482">Benzeneacetamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010881">Piperidones</NameOfSubstance></Chemical><Chemical><RegistryNumber>16VY3TM7ZO</RegistryNumber><NameOfSubstance UI="C052091">antineoplaston A10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044482" MajorTopicYN="N">Benzeneacetamides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010881" MajorTopicYN="N">Piperidones</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus A10 (CV-A10)</Keyword><Keyword MajorTopicYN="N">Hand, Foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">Non-human primate model</Keyword><Keyword MajorTopicYN="N">Pathogenic analysis</Keyword><Keyword MajorTopicYN="N">Rhesus macaque</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35777657</ArticleId><ArticleId IdType="pmc">PMC9437613</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2022.06.007</ArticleId><ArticleId IdType="pii">S1995-820X(22)00113-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>B'Krong N., Minh N., Qui P., Chau T., Nghia H., Do L., Nhung N., Van Vinh Chau N., Thwaites G., Van Tan L., Thanh T. Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet Nam 1997&#x2013;2010. Virol. J. 2018;15:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5897964</ArticleId><ArticleId IdType="pubmed">29650033</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Gao F., Mao Q., Sun S., Wu X., Liu S., Yang X., Liang Z. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems. Expert Rev. Anti Infect. Ther. 2019;17:233&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">30793637</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Lin T., Hsu K., Huang Y., Lee C. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682&#x2013;1686.</Citation><ArticleIdList><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Tsao K., Hsia S., Shih S., Huang C., Chan W., Hsu K., Fang T., Huang Y. Transmission and clinical features of enterovirus 71 infections in household contacts in taiwan. JAMA. 2014;291:222&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N., Kim K. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008;323:275&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuschino M., Lamson D., Rush K., Carbone L., Taff M., Hua Z., Landi K., George K. Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case. J.&#xa0;Clin. Virol. 2012;53:259&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">22209288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazarian L., Diana J., Beaudoin L., Larsson P., Puri R., Van Rooijen N., Flodstr&#xf6;m-Tullberg M., Lehuen A. Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages. Diabetes. 2013;62:3785&#x2013;3796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3806597</ArticleId><ArticleId IdType="pubmed">23894189</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;es P., Paola D., Brunolobo M., Dias L. Myocarditis produced by Coxsackie virus group A. An. Microbiol. 1959;7:13&#x2013;34.</Citation></Reference><Reference><Citation>Gonzalez G., Carr M., Kobayashi M., Hanaoka N., Fujimoto T. Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world. Int. J. Mol. Sci. 2019;20:5201&#x2013;5216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834195</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Chen L., Xu W., Yang H., Wang H., Zong W., Xian H., Chen H., Yao X., Hu Z. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus A6- and coxsackievirus A10-associated hand, foot, and mouth disease infections from 2008 to 2012 in shenzhen, China. J.&#xa0;Clin. Microbiol. 2013;51:3560&#x2013;3566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889734</ArticleId><ArticleId IdType="pubmed">23966496</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Zhang M., Chen Zhao, Zheng P., Zhang X., Xu J. From monovalent to multivalent vaccines, the exploration for potential preventive strategies against hand, foot, and mouth disease (HFMD) Virol. J. 2021;36:167&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525078</ArticleId><ArticleId IdType="pubmed">32997323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Zhang Z., Rao Q., Qang X., Wang M., Du T., Tantg J., Long S., Zhang J., Luo J., Pan Y., Chen J. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China. Emerg. Microb. Infect. 2021;10:619&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018479</ArticleId><ArticleId IdType="pubmed">33682641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kis&#xe1;ry J., Barta A. Method of determining virus neutralizing antibodies and the viral titer. Veterinariia. 1974;11:121&#x2013;122. (In Russian).</Citation><ArticleIdList><ArticleId IdType="pubmed">4456748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyosuke I., Katsunori F., Hironobu K., Masayoshi S., Katsuhiko K., Akihito H. Anterior cingulate cortex involvement in non-paraneoplastic limbic encephalitis. Brain Dev. 2019;41:735&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">31005361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xia X., Wang J. Innate immunity evasion by enteroviruses: insights into virus-host interaction. Viruses. 2016;8:22&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728582</ArticleId><ArticleId IdType="pubmed">26784219</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhao H., Yang L., Hou W., Xu L., Wu Y., Wang W., Chen C., Wan J., Ye X. A&#xa0;neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation. Antivir. Res. 2017;144:247&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">28625478</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Cai J., Ge Y., Zeng M. Non-polio enterovirus infections in children with central nervous system disorders in Shanghai, 2016-2018. Serotypes and clinical characteristics. 2020;129:104516&#x2013;104522.</Citation><ArticleIdList><ArticleId IdType="pubmed">32585621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd R., Tamhankar M., Lernmark A. Enteroviruses and type 1 diabetes: multiple mechanisms and factors? Annu. Rev. Med. 2022;73:483&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242008</ArticleId><ArticleId IdType="pubmed">34794324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q., Zhang X., Wo Y., Xu H., Li X., Wang X., Ding S., Chen X.D., He C., Liu L. Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009&#x2013;2011. PLoS One. 2012;7:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3525556</ArticleId><ArticleId IdType="pubmed">23272213</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Wang Y., Bian L., Xu M., Liang Z. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Emerg. Microb. Infect. 2016;5:e75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5141264</ArticleId><ArticleId IdType="pubmed">27436364</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A., Lemon S. Hepatitis A virus: from discovery to vaccines. Hepatology. 2010;43:S164&#x2013;S172.</Citation><ArticleIdList><ArticleId IdType="pubmed">16447259</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS. Microbiol. Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch M., Oberste M., Whitton J. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. A&#xa0;Practical Guide to Clinical Virology. 2003;14:44&#x2013;45.</Citation></Reference><Reference><Citation>Ping S., Wu X., Li H., Wu Z., Yang Z., Yao H. Clinical significance of inflammatory cytokine and chemokine expression in hand, foot and mouth disease. Mol. Med. Rep. 2017;15:2859&#x2013;2866.</Citation><ArticleIdList><ArticleId IdType="pubmed">28447721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafik H., Thomas B., Olivier D., Fatima D., Shabir O., Mahjoub A., Bruno P. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. J.&#xa0;Med. Virol. 2010;74:283&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">15332278</ArticleId></ArticleIdList></Reference><Reference><Citation>Serreze D., Ottendorfer E., Ellis T. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes. 2000;49:708&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">10905477</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L., Chen C., Huang D., Wang R., Zhang M., Qian L., Zhu Y., Zhang A.Z., Yang E., Qaqish A. Pathogenic events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis. J.&#xa0;Virol. 2017;91:e02310&#x2013;2316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5487571</ArticleId><ArticleId IdType="pubmed">28356537</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalkup J., Chilukuri S. Enterovirus infections: a review of clinical presentation, diagnosis, and treatment. Dermatol. Clin. 2002;20:217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">12120436</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauriainen S., Oikarinen S., Oikarinen M., Hy&#xf6;ty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin. Immunopathol. 2011;33:45&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">20424841</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor W., Samir S., Warren W.C., Kibet S., Shem K., John O., Hassan A., Messeret E., Melissa C., Satish P. Forewarning of poliovirus outbreaks in the Horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya. J.&#xa0;Infect. Dis. 2014;210:S85&#x2013;S90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4638114</ArticleId><ArticleId IdType="pubmed">25316880</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung W., Rawlinson W., Craig M. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342 421-421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3033438</ArticleId><ArticleId IdType="pubmed">21292721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Zhang T., Hu Y., Wang X., Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in china, 2009. Virol. J. 2011;8:508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung W., Al-Shabeeb A., Pang C., Wilkins M., Catteau J., Howard N., Rawlinson W., Craig M. Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes. 2012;61:1500&#x2013;1508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3357262</ArticleId><ArticleId IdType="pubmed">22474026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Z., Wei C., Liu L., Wang J., Qihan L. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 2011;91:1337&#x2013;1350.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylipaasto P., Smura T., Gopalacharyulu P., Paananen A., Sepp&#xe4;nen-Laakso T., Kaijalainen S., Ahlfors H., Korsgren O., Lakey J., Lahesmaa R., Piemonti L., Oresic M., Galama J., Roivainen M. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction. Diabetologia. 2012;55:3273&#x2013;3283.</Citation><ArticleIdList><ArticleId IdType="pubmed">22983635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Dong Z., Li J., Carr M., Zhuang D., Wang J. Protective efficacies of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection. J.&#xa0;Virol. 2017;91:e00333&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469256</ArticleId><ArticleId IdType="pubmed">28424287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>